Built for biotech R&D teams that move fast.
Drug discovery, biologics, cell-line work. The same workspace handles small molecules, biomolecules, and assay data — without forcing your scientists to reshape their work to fit the tool.
What slows your lab down today
The familiar pains.
Rigid documentation
The "official" ELN doesn't fit the workflow, so the real notebook lives in OneNote or a stack of PDFs. The auditable record diverges from the scientific record.
IP traceability gaps
Inventor-of-record questions get harder every quarter. Discovery cuts across chemistry, biology, and assay teams whose tools don't talk to each other.
Mixed-modality sprawl
Small molecules in one system. Cell lines in another. Biologics in a third. Your program leads spend more time correlating than discovering.
Cross-team friction
The medicinal chemists work one way, the bench biologists another, and the analytical scientists a third. The shared LIMS demands a single rigid template.
How Labitron helps
The pieces, in plain language.
A flexible editor every team can adapt
Block-based pages with templates per team. Chemists get a small-molecule template; biologists get a cell-line template; both link into the same project record.
One sample model, many sample types
Compounds, cell lines, biologics, animal subjects — all share the same lifecycle, audit trail, and chain-of-custody primitives. Different metadata, same record shape.
AI for drug-discovery insight
"Show me potency trends across the lead series in the last 90 days." Grounded in your real assay data; clickable back to the underlying records.
GxP-ready audit trails
Every record event is time-stamped and user-attributed. E-signatures with reason capture. Immutable history. Inspector-ready on demand.
What you get out of the box
Pre-configured for biotech.
Get started
See Labitron for biotech R&D.
A 30-minute walkthrough — bring a real workflow and we'll model it on the demo.